EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Lymph node ratio as an indicator of nodal status in the assessment of survival and recurrence in vulvar cancer: A cohort study

Houyem Mansouri, Ines Zemni iD, Saida Sakhri iD, Mohamed Ali Ayadi, Nadia Boujelbene, Tarek Ben Dhiab

Women's Health · 2024

DOI: 10.1177/17455057241285396 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Women's Health, 2024. Verfasst von Houyem Mansouri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Regional Hospital of Jendouba, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia. Hauptthemen laut MEDLINE: Vulvar Neoplasms, Carcinoma, Squamous Cell, Lymphatic Metastasis, Lymph Node Excision. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inguinal lymph node (LN) metastasis and particularly the number of metastatic lymph nodes (NMLN) represent a determinant prognostic factor in vulvar squamous cell carcinoma (VSCC). However, the NMLN may be related to the number of removed LNs. Therefore, the lymph node ratio (LNR) reflects not only the burden of LN involvement but also the quality and extent of lymphadenectomy.

Objectives

To investigate the value of the LNR and the count of LN on overall survival (OS) and recurrence-free survival (RFS).

Design

This study is a retrospective, longitudinal, institution-based study.

Methods

This study included 192 patients treated for VSCC at the Salah Azaiez Institute between 1994 and 2022. Clinical, pathological, and evolutionary data were reported. Survival curves were generated by the Kaplan–Meier method, and predictive factors of outcome were analyzed using Cox proportional hazards models.

Results

Surgery consisted of a radical vulvectomy, hemivulvectomy, and pelvic exenteration in, respectively, 96.4%, 2.1%, and 1.6% of cases followed by adjuvant radiotherapy in 38.5% of cases. LN dissection was bilateral in 88.5% of cases. LNR = 0, LNR = 0–0.2, and LNR ⩾0.2 were recorded in, respectively, 64.7%, 22.1%, and 13.2% of cases. With a mean follow-up time of 35 ± 42.06 months, the 5-year OS was 52.5% and the 5-year RFS was 55.8%. On multivariate analysis, the independent prognostic factors of OS were the LNR (hazard ratio (HR) = 5.702; 95% confidence interval (CI) = 2.282–14.245; p < 0.0001), Federation of Gynecology and Obstetrics (FIGO) stage (HR = 2.089; 95% CI = 1.028–4.277; p = 0.042), and free margins (HR = 2.247; 95% CI = 1.215–4.155; p = 0.01). Recurrences were recorded in 37.5% of cases. Independent prognostic factors of RFS were the LNR (HR = 2.911; 95% CI = 1.468–5.779; p = 0.002), FIGO stage (HR = 1.835; 95% CI = 1.071–3.141; p = 0.027), and free margins (HR = 2.091; 95% CI = 1.286–3.999; p = 0.003).

Conclusion

Surgical margin, FIGO stage, and LNR represent the independent prognostic factors of survival and LNR showed superior prognostic predictive accuracy compared with the revised 2021 FIGO staging system for predicting OS and RFS in VSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vulvar NeoplasmsCarcinoma, Squamous CellLymphatic MetastasisLymph Node ExcisionNeoplasm Recurrence, LocalLymph NodesLymph Node RatioHumansFemaleRetrospective StudiesMiddle AgedAgedPrognosisAdultCohort StudiesLongitudinal StudiesAged, 80 and overDisease-Free SurvivalNeoplasm StagingProportional Hazards Models

Stichwörter der Autor:innen

lymph node metastaseslymph node ratioprognosisrecurrencevulvar cancer

Autor:innen und Institutionen

  • Department of Surgical Oncology, Regional Hospital of Jendouba, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia.
  • Department of Surgical Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia.
  • Laboratory of Microorganisms and active Bio-molecules (LR03ES03), Faculty of Sciences of Tunis, University of Tunis El Manar, Tunisia.
  • Department of Pathology, Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia.

ORCID-Profile: Ines Zemni, Saida Sakhri

Zitieren

APA

Mansouri, H., Zemni, I., Sakhri, S., Ayadi, M. A., Boujelbene, N., & Ben Dhiab, T. (2024). Lymph node ratio as an indicator of nodal status in the assessment of survival and recurrence in vulvar cancer: A cohort study. Women's Health. https://doi.org/10.1177/17455057241285396

Vancouver

Mansouri H, Zemni I, Sakhri S, Ayadi MA, Boujelbene N, Ben Dhiab T. Lymph node ratio as an indicator of nodal status in the assessment of survival and recurrence in vulvar cancer: A cohort study. Women's Health. 2024. doi:10.1177/17455057241285396

BibTeX
@article{Mansouri2024,
  author = {Mansouri, Houyem and Zemni, Ines and Sakhri, Saida and Ayadi, Mohamed Ali and Boujelbene, Nadia and Ben Dhiab, Tarek},
  title = {Lymph node ratio as an indicator of nodal status in the assessment of survival and recurrence in vulvar cancer: A cohort study},
  journal = {Women's Health},
  year = {2024},
  doi = {10.1177/17455057241285396}
}
Kostenlos starten →